Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
06/2010
06/03/2010US20100137361 Tetrahydro-Quinolinylurea Derivatives
06/03/2010US20100137360 Trpv1 antagonists
06/03/2010US20100137359 Caspase inhibitors and uses thereof
06/03/2010US20100137345 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies
06/03/2010US20100137324 Rho-kinase inhibitors
06/03/2010US20100137321 IMIDAZO[1,2-a]AZINES AND THEIR USE AS PHARMACEUTICALS
06/03/2010US20100137319 Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith
06/03/2010US20100137300 Indolizine Acetic Acid Derivatives as CRTH2 Antagonists
06/03/2010US20100137268 Phthalazinone modulators of h1 receptors and/or ltc4 receptors
06/03/2010US20100137251 Functional Role for Cannabinoids in Autonomic Stability During Sleep
06/03/2010US20100137205 Use of FGF-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation
06/03/2010US20100137193 Chitosan derivatives to treat animals or optimize animal health
06/03/2010US20100136575 B7-related nucleic acids and polypeptides useful for immunomodulation
06/03/2010US20100136121 Medicaments
06/03/2010US20100136030 Antagonist ox40 antibodies and their use in the treatment of inflammatory and autoimmune diseases
06/03/2010US20100136020 Uses of il-174 antagonists for inhibiting a th2 immune response
06/03/2010US20100136008 TACI-Fc Fusion Proteins, Methods of Making and Uses Thereof
06/03/2010US20100136003 Uses of mammalian cytokine; related reagents
06/03/2010US20100135999 Quinoline-carboxamide derivatives as p2y12 antagonists
06/03/2010US20100135997 Polypeptide monomers and dimers containing mutated ilt
06/03/2010CA2745004A1 Pyridine-3-carboxyamide derivative
06/03/2010CA2744588A1 Ligands that bind il-13
06/02/2010EP2191831A1 Modifying pirfenidone treatment for patients with atypical liver function
06/02/2010EP2191718A1 Compounds and uses for the treatment of airway diseases and for the delivery of airway drugs
06/02/2010EP2190850A1 Small molecule correctors of deltaf508 cftr trafficking
06/02/2010EP2190825A1 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors
06/02/2010EP2190813A1 Carbamate stereoisomer
06/02/2010EP2190465A2 Use of a peptide as a therapeutic agent
06/02/2010EP2190464A2 Use of leptin(22-56) as a therapeutic agent
06/02/2010EP2190463A2 Use of thymopentin as a therapeutic agent
06/02/2010EP2190459A1 Use of cnp-22, alone1 or in combination with physalemin, as a therapeutic agent
06/02/2010EP2190456A2 Use of beta-melanotropin as a therapeutic agent, eg for the treatment of aids or alzheimer
06/02/2010EP2190453A2 Use of trp6-triptorelin and d-leu6-leuprolide as therapeutic agents
06/02/2010EP2190452A2 Use of a peptide as a therapeutic agent
06/02/2010EP2190450A2 Use of melanin concentrating hormone and met-enkephalin as therapeutic agents
06/02/2010EP2190447A2 Use of stresscopin-related peptide as a therapeutic agent
06/02/2010EP1830881B1 Combining therapies targeting multiple toll-like receptors and use thereof
06/02/2010EP1790643B1 Quinuclidine compounds having quaternary ammonium group, it's preparation method and use as blocking agents of acetycholine
06/02/2010EP1483228B1 Nk1 antagonists
06/02/2010CN1910178B Thiazole derivatives as A2B antagonists
06/02/2010CN1826336B Cyclohexanecarboxylic acid compound
06/02/2010CN1704123B Little interfered RNA preparation for internal preventing or curing respiratory system diseases and screening method thereof
06/02/2010CN1659180B Novel recombinant anticoagulant proteins
06/02/2010CN101717693A Artemisia frigida willd essential oil and preparation method and application thereof
06/02/2010CN101717692A Artemisia rutifolia essential oil and extraction process and application thereof
06/02/2010CN101717410A Phosphorus-containing compounds & uses thereof
06/02/2010CN101717356A Method for microwave synthesis of a phlegm eliminating drug Fuduositan
06/02/2010CN101716344A Pholcodine-containing compound pharmaceutical preparation for treating cold
06/02/2010CN101716329A Syrup for nourishing yin and clearing lung-heat
06/02/2010CN101716326A Medicament for treating children chronic cough and allergic rhinitis and preparation method thereof
06/02/2010CN101716300A Cough relief traditional Chinese medicine compound preparation and preparation method thereof
06/02/2010CN101716259A Traditional Chinese medicine composition of effective parts for treating cough and preparation method thereof
06/02/2010CN101716232A Quality control method of throat clearing dropping pill
06/02/2010CN101716218A Process for extracting rhododendron oil
06/02/2010CN101716215A Quality detection method of traditional Chinese medicine of isatis root
06/02/2010CN101716209A Artemisia dalai-lamae Krasch. essential oil and preparation method and application thereof
06/02/2010CN101716208A Volatile oil of Artemisia frigida var. atropurpurea and extraction process and application thereof
06/02/2010CN101716200A Medicinal composition for invigorating circulation blood and dredging collaterals and clearing heat and releasing toxin and preparation method and application thereof
06/02/2010CN101716171A Application of scutellarin extract in preparation medicaments for preventing and treating pulmonary fibrosis
06/02/2010CN101716162A Aminophylline slow-release capsules and preparation method thereof
06/02/2010CN101716141A Fleroxacin injection and preparation method thereof
06/02/2010CN101715956A Multifunctional health juice with stable effective ingredients and processing method thereof
06/02/2010CN101229199B Integrative extract method of multi-active ingredient in cordyceps militaris mycelium
06/02/2010CN101195005B Orally taken Chinese medicine composition for treating bronchiectasis
06/02/2010CN101185719B Medicinal composition for treating rhinitis and nasosinusitis
06/02/2010CN101181523B Chinese medicine prescription orally taken for curing bronchiolectasis
06/02/2010CN101181510B Chinese medicine composition orally taken for curing pulmonary emphysema
06/02/2010CN101181495B Prescription with ringing function and uses thereof
06/02/2010CN101181494B Chinese medicine composition orally taken for curing bronchial asthma
06/02/2010CN101181312B Method for preparing korean pine cone extract
06/02/2010CN101167939B Traditional Chinese medicine preparation for treating bronchiectasis and preparation method thereof
06/02/2010CN101167505B Selenium rich rabdosia rubescens tea
06/02/2010CN101129555B Medicine for curing acute bronchitis
06/02/2010CN101129532B Traditional Chinese medicine dispersible tablet for relieving cough and method of preparing the same
06/02/2010CN101116662B Application of sophocarpine in the preparation of medicine for treating adenovirus-caused inflammation
06/02/2010CN101099804B Traditional Chinese medicine composition for treating sars caused by epidemic poison retention lung and preparation method thereof
06/02/2010CN101085055B Traditional Chinese medicinal composition syrup for heat-clearing and toxin-removing, fire-draining and throat-moistening and its preparation method
06/02/2010CN101053583B Method for preparing chrysanthemum Ieucanthemum granules
06/01/2010US7728109 Antagonistic anti-hTNFSF13b human antibodies
06/01/2010US7728016 Substituted 5-membered ring compounds and their use
06/01/2010US7728005 such as N-(2-bromophenyl)-N'-[2-(4-fluorophenoxy)ethyl]urea, having superior antiinflammatory and analgesic activity
06/01/2010US7727998 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
06/01/2010US7727992 2-(3-Ethyl-ureido)-6-pyridin-3-yl-3H-benzoimidazole-4-carboxylic acid methyl ester; for treating bacterial infections in mammals; useful in treating or lessening severity of urinary tract infections, pneumonia, prostatitis, skin and soft tissue infections, intra-abdominal infections
06/01/2010US7727527 Anti-NGF antibodies for the therapeutic treatments
06/01/2010US7727519 Method for treating hepatitis C virus with omega interferon
06/01/2010CA2509775C Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers
06/01/2010CA2440699C Compounds for treating inflammatory diseases
06/01/2010CA2423007C Spiro derivatives and adhesion molecule inhibitors containing the same as effective ingredients
06/01/2010CA2409827C Arylmethylamine derivatives for use as tryptase inhibitors
06/01/2010CA2366750C (e)-styryl sulfone anticancer agents
05/2010
05/27/2010WO2010059610A1 6, 7 -dihydro- 5h- pyrrolo [3, 4-d] pyrimidin-4-yl] -quinolin-3 -ylamine compounds useful as faah modulators and uses thereof
05/27/2010WO2010059372A2 Tryptase enzyme inhibiting aminopyridines
05/27/2010WO2010058858A1 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
05/27/2010WO2010058846A1 4,6-diaminonicotinamide compound
05/27/2010WO2010058751A1 Pharmacologically acceptable salt of [1,3,4]oxadiazole compound or hydrate thereof
05/27/2010WO2010057275A1 Cyclic peptides and uses thereof
05/27/2010WO2010038155A3 Antibodies against il-25
05/27/2010WO2010013925A3 Pharmacological composition for prevention and treatment of respiratory disease containing pyrazolopyrimidinone compound or pharmaceutically acceptable salts thereof
05/27/2010US20100130547 Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide
05/27/2010US20100130542 Composition Comprising a Combination of Omeprazole and Lansoprazole, and a Buffering Agent, and Methods of Using Same
1 ... 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 ... 878